The NZX has confirmed it is assessing a second complaint lodged in relation to a Grant Samuel valuation report commissioned by medical investor Abano Healthcare [NZX: ABA].
The issue is one of many that rebel shareholders Peter Hutson and James Reeves are pushing in their bid to oust
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Duncan Bridgeman
Fri, 06 Jun 2014
Fri, 06 Jun 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
NZX assessing further complaint over Grant Samuel's Abano report
38586